NCT03195764 2022-11-18
Safety and Tolerability Study for T-1101 (Tosylate) to Treat Advanced Refractory Solid Tumors
Taivex Therapeutics Corporation
Phase 1 Terminated
Clinical Trials
5 trialsNCT03349073 2022-11-18
An Extension Study for T-1101 (Tosylate) to Treat Advanced Refractory Solid Tumors
Taivex Therapeutics Corporation
Phase 1 Completed
NCT04324372 2022-08-12
Clinical Study of HEC68498 in Patients With Advanced Refractory Solid Tumors
Sunshine Lake Pharma Co., Ltd.
Phase 1 Completed
NCT01762410 2014-09-29
Clinical Study of Oral PI3K/mTOR Inhibitor in Patients With Advanced Refractory Solid Tumors
Piramal Enterprises Limited
Phase 1 Suspended
NCT01779336 2014-09-29
Clinical Study of Oral IGF-1R Inhibitor in Subjects With Advanced Refractory Solid Tumors
Piramal Enterprises Limited
Phase 1 Suspended